Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations

Am J Trop Med Hyg. 2021 Oct 4;105(6):1608-1617. doi: 10.4269/ajtmh.21-0401.

Abstract

Serological surveillance for vaccine-preventable diseases, such as measles and rubella, can provide direct measures of population immunity across age groups, identify gaps in immunity, and document changes in immunity over time. Rigorously conducted, representative household serosurveys provide high-quality estimates with minimal bias. However, they can be logistically challenging, expensive, and have higher refusal rates than vaccine coverage surveys. This article shares lessons learned through implementing nine measles and rubella household serosurveys in five districts in India-the challenges faced, the potential impact on results, and recommendations to facilitate the conduct of serosurveys. Specific lessons learned arose from challenges related to community mobilization owing to lack of cooperation in certain settings and populations, limitations of outdated census information, nonresponse due to refusal or unavailability during survey enumeration and enrollment, data collection issues, and specimen collection and handling issues. Although some experiences are specific to serosurveys in India, these lessons are generalizable to other household surveys, particularly vaccination coverage and serosurveys conducted in low- and middle-income settings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / immunology*
  • Child
  • Child, Preschool
  • Community Health Workers
  • Community Participation
  • Female
  • Humans
  • Implementation Science
  • India / epidemiology
  • Infant
  • Male
  • Measles / epidemiology
  • Measles / immunology*
  • Middle Aged
  • Rubella / epidemiology
  • Rubella / immunology*
  • Seroepidemiologic Studies
  • Serologic Tests
  • Specimen Handling
  • Vaccine-Preventable Diseases / epidemiology
  • Vaccine-Preventable Diseases / immunology*
  • Young Adult

Substances

  • Antibodies, Viral